Court Opinion

ID: 4241715
Source: CourtListenerOpinion
Date Created: 2018-02-02 13:04:19.910999+00
Date Added: 2024-06-11T09:36:46.485522
License: Public Domain

In the United States Court of Federal Claims
                                 OFFICE OF SPECIAL MASTERS
                                          No. 15-0762V
                                     Filed: August 16, 2017
                                         UNPUBLISHED

    TINA LAZICKI,
                                                             Special Processing Unit (SPU); Joint
                        Petitioner,                          Stipulation on Damages; Tetanus
    v.                                                       Diphtheria acellular Pertussis (Tdap)
                                                             Vaccine; Arm Pain, Numbness,
    SECRETARY OF HEALTH AND                                  Tingling, Paresthesia; Neuropathic
    HUMAN SERVICES,                                          Pain Syndrome

                       Respondent.

Mark T. Sadaka, Mark T. Sadaka, LLC, Englewood, NJ, for petitioner.
Sarah C. Duncan, U.S. Department of Justice, Washington, DC, for respondent.

                              DECISION ON JOINT STIPULATION 1

Dorsey, Chief Special Master:

        On July 21, 2015, Tina Lazicki (“petitioner”) filed a petition for compensation
under the National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et
seq., 2 (the “Vaccine Act”). Petitioner alleges that she suffered left arm pain, numbness,
tingling, and paresthesia, and/or neuropathic pain syndrome, as a result of receiving the
tetanus, diphtheria, acellular pertussis (“Tdap”) vaccine on August 1, 2012. Petition at
1-4; Stipulation, filed August 16, 2017, at ¶¶ 1, 2, 4. Petitioner further alleges that she
suffered the residual effects of her alleged injuries for more than six months. Petition at
¶ 16; Stipulation at ¶ 4. Respondent denies that the Tdap vaccine caused petitioner to
suffer from left arm pain, numbness, tingling, and paresthesia, and/or neuropathic pain
syndrome, or any other injury. Stipulation at ¶ 6.

       Nevertheless, on August 16, 2017, the parties filed the attached joint stipulation,
stating that a decision should be entered awarding compensation. The undersigned

1 Because this unpublished decision contains a reasoned explanation for the action in this case, the
undersigned intends to post it on the United States Court of Federal Claims' website, in accordance with
the E-Government Act of 2002. 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of
Electronic Government Services). In accordance with Vaccine Rule 18(b), petitioner has 14 days to
identify and move to redact medical or other information, the disclosure of which would constitute an
unwarranted invasion of privacy. If, upon review, the undersigned agrees that the identified material fits
within this definition, the undersigned will redact such material from public access.

2National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for
ease of citation, all “§” references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. §
300aa (2012).
finds the stipulation reasonable and adopts it as the decision of the Court in awarding
damages, on the terms set forth therein.

     Pursuant to the terms stated in the attached Stipulation, the undersigned
awards the following compensation:

        A lump sum of $90,000.00 in the form of a check payable to petitioner.
        Stipulation at ¶ 8. This amount represents compensation for all items of
        damages that would be available under 42 U.S.C. § 300aa-15(a). Id.

       The undersigned approves the requested amount for petitioner’s compensation.
In the absence of a motion for review filed pursuant to RCFC Appendix B, the clerk of
the court is directed to enter judgment in accordance with this decision. 3

IT IS SO ORDERED.

                                          s/Nora Beth Dorsey
                                          Nora Beth Dorsey
                                          Chief Special Master

3 Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by the parties’ joint filing of notice

renouncing the right to seek review.

                                                      2